rent funding for pain and opioid research at the National 
Institutes of Health. 
(b) ACCEPTANCE OF DONATIONS.—Notwithstanding 
section 1342 of title 31, United States Code, the Secretary 
of Health and Human Services may accept donations (in-
cluding from the pharmaceutical and medical device indus-
tries) to be used to assist in carrying out programs and 
activities under this Act (and the amendments made by 
this Act). Such donations shall be paid to the Foundation 
for the National Institutes of Health and transferred to 
the NIH Innovation Account to be used for the Opioids 
and STOP Pain Initiative established under section 2. 
(c) INCLUSION
OF CONTRIBUTION AMOUNTS
IN 
BASIC RESEARCH FOR PURPOSES OF RESEARCH CRED-
IT.— 
(1) IN
GENERAL.—Paragraph (6) of section 
41(e) of the Internal Revenue Code of 1986 is 
amended by adding at the end the following new 
subparagraph: 
‘‘(E) OPIOIDS
AND
STOP
PAIN
INITIA-
TIVE.—The National Institutes of Health, if the 
payment is made in support of the Opioids and 
STOP Pain Initiative, as established by the 
Opioids and STOP Pain Initiative Act.’’. 
VerDate Sep 11 2014 
16:29 Dec 23, 2017
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4733.IH
H4733
ethrower on DSK3G9T082PROD with BILLS
(2) EFFECTIVE DATE.—The amendments made 
by this subsection shall apply to taxable years begin-
ning after the date of the enactment of this Act. 
SEC. 6. AUTHORITY. 
Notwithstanding any other provision of the law, the 
Director of the National Institutes of Health may use 
funds available under section 3 to enter into transactions 
(other than contracts, cooperative agreements, or grants) 
to carry out research identified pursuant to the Opioids 
and STOP Pain Initiative established under section 2. 
SEC. 7. REPORTS. 
(a) ANNUAL REPORTS.—Not later than October 1 of 
each of fiscal years 2019 through 2026, the Director of 
the National Institutes of Health shall submit to the Com-
mittee on Health, Education, Labor, and Pensions and the 
Committee on Appropriations of the Senate and the Com-
mittee on Energy and Commerce and the Committee on 
Appropriations of the House of Representatives, a report 
that includes— 
(1) the amount obligated or expended in the fis-
cal year prior to the fiscal year in which the report 
is being submitted for each program or activity de-
scribed in this Act (or an amendment made by this 
Act); 
VerDate Sep 11 2014 
16:29 Dec 23, 2017
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4733.IH
H4733
ethrower on DSK3G9T082PROD with BILLS
(2) a description of all such programs or activi-
ties carried out using funds provided under this Act 
(or amendments); and 
(3) a description of how such programs or ac-
tivities are advancing public health, including the 
impact on treating pain and addressing opioid mis-
use in the United States. 
(b) ADDITIONAL REPORTS.—At the request of the 
Committee on Health, Education, Labor, and Pensions or 
the Committee on Appropriations of the Senate, or the 
Committee on Energy and Commerce or the Committee 
on Appropriations of the House of Representatives, the 
Director of the National Institutes of Health shall provide 
to the relevant committee an update in the form of testi-
mony and additional reports concerning the allocation of 
funding under this Act (or the amendments made by this 
Act) or the description of the programs and activities car-
ried out with such funding. 
Æ 
VerDate Sep 11 2014 
16:29 Dec 23, 2017
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6301
E:\BILLS\H4733.IH
H4733
ethrower on DSK3G9T082PROD with BILLS